MJT & Associates Financial Advisory Group »

Sarepta Therapeutics shares owned by MJT & Associates Financial Advisory Group

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by MJT & Associates Financial Advisory Group from 13F filings

Historical chart of MJT & Associates Financial Advisory Group investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by MJT & Associates Financial Advisory Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by MJT & Associates Financial Advisory Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.5k 69 21.52

More positions owned by MJT & Associates Financial Advisory Group

Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Ishares S&p 500 Growth Etf Etf (IVW)
Schwab Us Dividend Equity Etf Etf (SCHD)
Ishares 0-5 Year Tips Bond Etf Etf (STIP)
Wisdomtree U.s. Midcap Dividend Fund Etf (DON)
Ishares Ultra Short Duration Bond Active Etf Etf (ICSH)
Ishares Msci Emerging Markets Ex China Etf Etf (EMXC)
Jpmorgan Ultra-short Income Etf Etf (JPST)
Ishares Core S&p Small Cap Etf Etf (IJR)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Vanguard Mid-cap Growth Etf Etf (VOT)
Vanguard Mid-cap Value Etf Etf (VOE)
Ishares S&p 500 Value Etf Etf (IVE)
Vanguard Small Cap Value Etf Etf (VBR)
State Street Spdr Portfolio S&p 500 Etf Etf (SPYM)

View all positions for MJT & Associates Financial Advisory Group

Top funds holding Sarepta Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Susquehanna International
Erste Asset Management GmbH
Standard Life Aberdeen
Two Sigma Investments
D. E. Shaw & Co
UBS Group
First Trust Advisors
Two Sigma Advisers
Geode Capital Management
LMR Partners
Citadel Advisors
AQR Capital Management

View all funds holding Sarepta Therapeutics